415 related articles for article (PubMed ID: 14616419)
1. Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications.
Labiris NR; Dolovich MB
Br J Clin Pharmacol; 2003 Dec; 56(6):600-12. PubMed ID: 14616419
[TBL] [Abstract][Full Text] [Related]
2. Propellant-driven metered-dose inhalers for pulmonary drug delivery.
Smyth HD
Expert Opin Drug Deliv; 2005 Jan; 2(1):53-74. PubMed ID: 16296735
[TBL] [Abstract][Full Text] [Related]
3. The PulmoSphere™ platform for pulmonary drug delivery.
Weers J; Tarara T
Ther Deliv; 2014 Mar; 5(3):277-95. PubMed ID: 24592954
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary vaccine delivery.
Lu D; Hickey AJ
Expert Rev Vaccines; 2007 Apr; 6(2):213-26. PubMed ID: 17408371
[TBL] [Abstract][Full Text] [Related]
5. The expanding role of aerosols in systemic drug delivery, gene therapy, and vaccination.
Laube BL
Respir Care; 2005 Sep; 50(9):1161-76. PubMed ID: 16122400
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in aerosol devices for the delivery of inhaled medications.
Ari A; Fink JB
Expert Opin Drug Deliv; 2020 Feb; 17(2):133-144. PubMed ID: 31959028
[No Abstract] [Full Text] [Related]
7. Development of dry powder inhalers.
Chougule MB; Padhi BK; Jinturkar KA; Misra A
Recent Pat Drug Deliv Formul; 2007; 1(1):11-21. PubMed ID: 19075871
[TBL] [Abstract][Full Text] [Related]
8. The twin impinger: a simple device for assessing the delivery of drugs from metered dose pressurized aerosol inhalers.
Hallworth GW; Westmoreland DG
J Pharm Pharmacol; 1987 Dec; 39(12):966-72. PubMed ID: 2894443
[TBL] [Abstract][Full Text] [Related]
9. Inhalation aspects of therapeutic aerosols.
Leach CL
Toxicol Pathol; 2007 Jan; 35(1):23-6. PubMed ID: 17325969
[TBL] [Abstract][Full Text] [Related]
10. Inhalation therapy of the future--how will it change the way we treat asthma?
Lötvall J
J Aerosol Med; 2001; 14 Suppl 1():S45-50. PubMed ID: 11424893
[TBL] [Abstract][Full Text] [Related]
11. The role of particle properties in pharmaceutical powder inhalation formulations.
Chew NY; Chan HK
J Aerosol Med; 2002; 15(3):325-30. PubMed ID: 12396421
[TBL] [Abstract][Full Text] [Related]
12. Effective inhaled drug administration to mechanically ventilated patients.
Dhand R; Mercier E
Expert Opin Drug Deliv; 2007 Jan; 4(1):47-61. PubMed ID: 17184162
[TBL] [Abstract][Full Text] [Related]
13. The nanoscale in pulmonary delivery. Part 2: formulation platforms.
Rogueda PG; Traini D
Expert Opin Drug Deliv; 2007 Nov; 4(6):607-20. PubMed ID: 17970664
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary drug delivery: novel pharmaceutical technologies breathe new life into the lungs.
Nanjwade BK; Adichwal SA; Gaikwad KR; Parikh KA; Manvi FV
PDA J Pharm Sci Technol; 2011; 65(5):513-34. PubMed ID: 22293840
[TBL] [Abstract][Full Text] [Related]
15. Electrostatics of pharmaceutical inhalation aerosols.
Kwok PC; Chan HK
J Pharm Pharmacol; 2009 Dec; 61(12):1587-99. PubMed ID: 19958580
[TBL] [Abstract][Full Text] [Related]
16. History of aerosol therapy: liquid nebulization to MDIs to DPIs.
Anderson PJ
Respir Care; 2005 Sep; 50(9):1139-50. PubMed ID: 16122398
[TBL] [Abstract][Full Text] [Related]
17. Air and soul: the science and application of aerosol therapy.
Rubin BK
Respir Care; 2010 Jul; 55(7):911-21. PubMed ID: 20587104
[TBL] [Abstract][Full Text] [Related]
18. The function and performance of aqueous aerosol devices for inhalation therapy.
Carvalho TC; McConville JT
J Pharm Pharmacol; 2016 May; 68(5):556-78. PubMed ID: 27061412
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary formulations: what remains to be done?
Weers JG; Bell J; Chan HK; Cipolla D; Dunbar C; Hickey AJ; Smith IJ
J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23 Suppl 2():S5-23. PubMed ID: 21133800
[TBL] [Abstract][Full Text] [Related]
20. Aerosol drug delivery: developments in device design and clinical use.
Dolovich MB; Dhand R
Lancet; 2011 Mar; 377(9770):1032-45. PubMed ID: 21036392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
